Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigurdur Gudjónsson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Urology and Nephrology|August 27, 2009
Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?Christian Lindberg, Thomas Davidsson, Sigurdur Gudjónsson, et al.
BJU International|November 1, 2011
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS)Sigurdur Gudjónsson, Mats Bläckberg, Gunilla Chebil, et al.
Scandinavian Journal of Urology and Nephrology|April 21, 2011
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?Sigurdur Gudjónsson, Pär-Ola Bendahl, Gunilla Chebil, et al.
European Urology|December 18, 2007
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancerSigurdur Gudjónsson, Björn L Isfoss, Kerstin Hansson, et al.
European Urology|January 21, 2009
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre studySigurdur Gudjónsson, Lars Adell, Fekadu Merdasa, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Urology and Nephrology|August 27, 2009
Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?Christian Lindberg, Thomas Davidsson, Sigurdur Gudjónsson, et al.
BJU International|November 1, 2011
The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS)Sigurdur Gudjónsson, Mats Bläckberg, Gunilla Chebil, et al.
Scandinavian Journal of Urology and Nephrology|April 21, 2011
Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?Sigurdur Gudjónsson, Pär-Ola Bendahl, Gunilla Chebil, et al.
European Urology|December 18, 2007
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancerSigurdur Gudjónsson, Björn L Isfoss, Kerstin Hansson, et al.
European Urology|January 21, 2009
Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre studySigurdur Gudjónsson, Lars Adell, Fekadu Merdasa, et al.
Pageof 1